Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0871-2023

Drug recall · June 21, 2023

Lysteda recall

Why: Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Lysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30

Lots / codes

Lots: X220317A and X220318A, exp. date 09/25

Quantity
48,989 bottles
Company
Amring Pharmaceuticals Inc, Berwyn, PA
Distribution
Nationwide in the USA.
Initiated
June 12, 2023 · Voluntary: Firm initiated
Classified
June 14, 2023
Reported
June 21, 2023
Ended
May 29, 2024
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Tranexamic acid

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.